Patient Guide: A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 49 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04958239
Status: 🟢 Enrolling Now
Condition: Neoplasms
Phase: PHASE1

Where You Can Participate

This study is available at 49 locations across the country.

Top locations include:
  • • Tucson, Arizona
  • • Beverly Hills, California
  • • Chapel Hill, North Carolina
  • • And 46 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer - Join Clinical Trial NCTNCT04958239

How to Join This Clinical Trial - NCTNCT04958239

Learn how to participate in this PHASE1 trial studying an investigational therapy for Neoplasms. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Neoplasms. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Neoplasms
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04958239 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 49 locations. Find a study site near you:

Clinical Research Site

Tucson, Arizona 85719 - United States

Status: RECRUITING

Clinical Research Site

Beverly Hills, California 90211 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Chapel Hill, North Carolina 27514 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Sioux Falls, South Dakota 57105 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

San Antonio, Texas 78229 - United States

Status: RECRUITING

Clinical Research Site

Albury, New South Wales 2640 - Australia

Status: NOT_YET_RECRUITING

Clinical Research Site

Darlinghurst, New South Wales 2010 - Australia

Status: RECRUITING

Clinical Research Site

Douglas, Queensland 4814 - Australia

Status: NOT_YET_RECRUITING

Clinical Research Site

Heidelberg, Victoria 3084 - Australia

Status: RECRUITING

Clinical Research Site

Bruxelles, 1200 - Belgium

Status: RECRUITING

And 39 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Neoplasms:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships